Feb 26, 2016 13:00 pm UTC| Business
Fourth Quarter Highlights: Net income of $5.0 million, or $0.10 per diluted common shareAFFO of $7.0 million, or $0.14 per diluted common share1Recorded gains of $3.8 million from the sales of real estate assetsEarned $1.3...
Chiasma to Report Fourth Quarter and Year End 2015 Financial Results on March 14
Feb 26, 2016 13:00 pm UTC| Business
NEWTON, Mass., Feb. 26, 2016 -- Chiasma, Inc. (NASDAQ:CHMA), a late-stage biopharmaceutical company developing Mycapssa™ (octreotide) capsules, a new investigational oral drug for the potential maintenance therapy of...
Feb 26, 2016 13:00 pm UTC| Business
FAIRFAX, Va., Feb. 26, 2016 -- The Department of the Navy, Naval Facilities Engineering Command (NAVFAC) Southwest has awarded ManTech (Nasdaq:MANT), in a joint venture with AECOM, a $30 million firm-fixed-price,...
Feb 26, 2016 13:00 pm UTC| Business
Year over year quarterly revenue and adjusted EBITDA growth of 10% and 44% respectivelyYear over year full year revenue and adjusted EBITDA growth of 9% and 31% respectivelyExceeded the high end of the 2015 financial...
Feb 26, 2016 12:30 pm UTC| Business
WEST PALM BEACH, Fla., Feb. 26, 2016 -- Platform Specialty Products Corporation (NYSE:PAH) ("Platform") announced today that it will hold a conference call to discuss its 2015 fourth quarter and full year financial...
Otonomy to Report Fourth Quarter and Full Year 2015 Financial Results and Provide Corporate Update
Feb 26, 2016 12:30 pm UTC| Business
SAN DIEGO, Feb. 26, 2016 -- Otonomy, Inc.(NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced it...
Feb 26, 2016 12:30 pm UTC| Business
WARRENDALE, Pa., Feb. 26, 2016 -- rue21, inc., a leading teen specialty apparel retailer and one of the top 100 brands for millennials, today announced its Spring 2016 partnership with the Fashion Institute of...